Table 5 Overall survival by treatment status and histologic categories
Overall | Survival from initial diagnosis of advanced STS | |||||
|---|---|---|---|---|---|---|
Total | Died | Censored | Median length of survival (in months) | 95% CI | ||
All advanced STS patients | 4274 | 3565 | 709 | 8.9 | 8.3 | 9.7 |
Treatment status | ||||||
Received cancer-directed treatment | 2656 | 2185 | 471 | 13.6 | 12.9 | 14.6 |
Received supportive care only | 1618 | 1380 | 238 | 2.8 | 2.6 | 3.4 |
Histologic categories | ||||||
Fibroblastic/myofibroblastic sarcomas | 227 | 160 | 67 | 21.4 | 15.6 | 26.8 |
Leiomyosarcomas | 922 | 781 | 141 | 12.9 | 10.9 | 14.6 |
Liposarcomas | 554 | 395 | 159 | 21.1 | 17.4 | 27.1 |
Nerve sheath sarcomas | 106 | 88 | 18 | 6.2 | 3.6 | 9.3 |
Rhabdomyosarcomas | 98 | – | – | 3.0 | 1.8 | 5.7 |
Synovial sarcomas | 49 | – | – | 8.6 | 5.3 | 13.8 |
Undifferentiated pleomorphic sarcomas | 652 | 539 | 113 | 9.6 | 8.2 | 11.4 |
Vascular sarcomas | 357 | 327 | 30 | 6.0 | 4.8 | 7.3 |
Others/NOS | 1309 | 1139 | 170 | 5.4 | 4.8 | 6.1 |